Tenet Healthcare Corporation reported $21.8B of revenue over the trailing twelve months, +5.4% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $21.8B (to Q2 2026). Net income: $3.17B, trailing twelve months to Q2 2026. Free cash flow: $3.02B, trailing twelve months to Q2 2026. Operating margin: 21%, trailing twelve months to Q2 2026.

THCTenet Healthcare Corporation

Healthcare

$263.83+39% 1Y

$263.83

$161.3752 weeks$280.73

THC as reported

Tenet Healthcare Corporation reported $21.8B of revenue over the trailing twelve months, +5.4% on the year before. 10 reported series are charted on this page, each one as filed.

$21.8B

Revenue, trailing twelve months · to Q2 2026 · +5.4% against the twelve months before

Net income: $3.17B
Net income · +32% year on year · trailing twelve months to Q2 2026
Free cash flow: $3.02B
Free cash flow · +95% year on year · trailing twelve months to Q2 2026
Operating margin: 21%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for THC, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$21.8B	+5.4%	Q2 2026
Net income	$3.17B	+32%	Q2 2026
EPS	$25.92	+65%	Q2 2026
Operating margin	21%	n/a	Q2 2026
Net margin	15%	n/a	Q2 2026
ROE	59%	n/a	Q2 2026
ROA	8.7%	n/a	Q2 2026
ROIC	20%	n/a	Q2 2026
Free cash flow	$3.02B	+95%	Q2 2026
P/E	10.2	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.